Potential pitfalls in incorporating plasma Epstein-Barr virus DNA in the management of nasopharyngeal carcinoma.
Edwin C Y WongJessica L C HungWai Tong NgPublished in: Head & neck (2019)
Posttreatment EBV DNA, particularly at 26 weeks post-radiotherapy, has high prognostic and predictive values. Surveillance endoscopy/imaging are recommended for the detection of local recurrence.
Keyphrases
- epstein barr virus
- circulating tumor
- diffuse large b cell lymphoma
- cell free
- single molecule
- high resolution
- early stage
- public health
- radiation therapy
- nucleic acid
- squamous cell carcinoma
- radiation induced
- circulating tumor cells
- free survival
- small bowel
- label free
- mass spectrometry
- human health
- climate change
- rectal cancer